916065-16-2

Upstream product

• 78495-63-3 (2-fluoro-6-methoxyphenyl)boronic acid 
• 824-94-2 p-methoxybenzyl chloride 
• 896467-74-6 methyl 1-(4-methoxybenzyl)-4-nitro-1H-pyrazole-3-carboxylate 
• 916065-15-1 5,7-dichloro-2-(4-methoxybenzyl)-2H-pyrazolo[4,3-d]pyrimidine 
• 916178-96-6 Potassium 2-fluoro-6-methoxyphenyltrifluoroborate 

Downstream Products

• 916065-17-3 N-[2-Chloro-4-(trifluoromethyl)phenyl]-7-(2-fluoro-6-methoxyphenyl)-2-(4-methoxybenzyl)-2H-pyrazolo[4,3-d]pyrimidine-5-amine 
• 916062-65-2 N-[2-chloro-4-(trifluoromethyl)phenyl]-N-ethyl-7-(2-methoxy-6-fluorophenyl)-1H-pyrazolo[4,3-d]pyrimidine-5-amine 
• 916065-18-4 N-[2-Chloro-4-(trifluoromethyl)phenyl]-N-ethyl-7-(2-fluoro-6-methoxyphenyl)-2-(4-methoxybenzyl)-2H-pyrazolo[4,3-d]pyrimidine-5-amine 

Relevant academic research and scientific papers

PYRAZOLOPYRIMIDINE DERIVATIVE

A pyrazolopyrimidine derivative of the formula [I] wherein R1 is an optionally substituted aromatic ring group, an optionally substituted lower alkyl group or an optionally substituted amino group; R2 is an optionally substituted aromatic ring group; R3 is an optionally substituted lower alkyl group; and R4 is a hydrogen atom, a lower alkyl group, a halogen atom, a nitro group or an amino group; or a pharmaceutically acceptable salt thereof is useful as an antagonist of CRF receptor.